Literature DB >> 18600320

Investigations into the ability of the peptide, HAL18, to interact with bacterial membranes.

Sarah R Dennison1, Young Soo Kim, Hyung Joon Cha, David A Phoenix.   

Abstract

Halocidin was isolated from hemocytes, Halocynthia aurantium as a heterodimeric peptide consisting of two alpha-helical subunits, Hal15 and Hal18. Hal18 was shown to have antibacterial properties against Bacillus subtilis (MLC = 15 microM) and Escherichia coli (MLC = 100 microM). The peptide was shown to produce stable monolayers, which were characteristic of alpha-helical peptides predicted to orientate parallel to the surface of the interface. Constant area assays showed that Hal18 was surface active (4 microM) inducing surface pressure changes >30 mN m(-1) characteristic of membrane interactive peptides. The peptide induced stable surface pressure changes in monolayers that were mimetic of B. subtilis membranes (circa 7 mN m(-1)) and E. coli membrane-mimics (circa 4 mN m(-1)). Hal18 inserted readily into zwitterionic DOPE and anionic DOPG monolayers inducing surface pressure changes circa 8 mN m(-1) in both cases, providing evidence that interaction is not headgroup specific. Thermodynamic analysis of compression isotherms showed that the presence of Hal18 destabilised B. subtilis membranes (DeltaG (Mix) > 0), which is in contrast to its stabilising effect on E. coli lipid extract implying the differential antimicrobial efficacy may be driven by lipid packing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600320     DOI: 10.1007/s00249-008-0352-6

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  27 in total

Review 1.  Amphipathic, alpha-helical antimicrobial peptides.

Authors:  A Tossi; L Sandri; A Giangaspero
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

Review 2.  Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems.

Authors:  K Lohner; E J Prenner
Journal:  Biochim Biophys Acta       Date:  1999-12-15

3.  Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli.

Authors:  Quande Wei; Young Soo Kim; Jeong Hyun Seo; Woong Sik Jang; In Hee Lee; Hyung Joon Cha
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

4.  Are oblique orientated alpha-helices used by antimicrobial peptides for membrane invasion?

Authors:  Sarah R Dennison; Frederick Harris; David A Phoenix
Journal:  Protein Pept Lett       Date:  2005-01       Impact factor: 1.890

Review 5.  Tilted peptides: the history.

Authors:  Annick Thomas; Robert Brasseur
Journal:  Curr Protein Pept Sci       Date:  2006-12       Impact factor: 3.272

6.  The interactions of aurein 1.2 with cancer cell membranes.

Authors:  Sarah R Dennison; Frederick Harris; David A Phoenix
Journal:  Biophys Chem       Date:  2006-12-22       Impact factor: 2.352

7.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

8.  Binding of hisactophilin I and II to lipid membranes is controlled by a pH-dependent myristoyl-histidine switch.

Authors:  F Hanakam; G Gerisch; S Lotz; T Alt; A Seelig
Journal:  Biochemistry       Date:  1996-08-27       Impact factor: 3.162

9.  Insertion selectivity of antimicrobial peptide protegrin-1 into lipid monolayers: effect of head group electrostatics and tail group packing.

Authors:  Yuji Ishitsuka; Duy S Pham; Alan J Waring; Robert I Lehrer; Ka Yee C Lee
Journal:  Biochim Biophys Acta       Date:  2006-08-05

10.  Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium.

Authors:  Woong Sik Jang; Kyu Nam Kim; Young Shin Lee; Myung Hee Nam; In Hee Lee
Journal:  FEBS Lett       Date:  2002-06-19       Impact factor: 4.124

View more
  5 in total

1.  Effect of salt on the interaction of Hal18 with lipid membranes.

Authors:  Sarah R Dennison; Adam J Phoenix; David A Phoenix
Journal:  Eur Biophys J       Date:  2012-08-15       Impact factor: 1.733

2.  Membrane interaction of antimicrobial peptides using E. coli lipid extract as model bacterial cell membranes and SFG spectroscopy.

Authors:  Lauren Soblosky; Ayyalusamy Ramamoorthy; Zhan Chen
Journal:  Chem Phys Lipids       Date:  2015-02-20       Impact factor: 3.329

3.  In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus.

Authors:  Linda B Oyama; Hamza Olleik; Ana Carolina Nery Teixeira; Matheus M Guidini; James A Pickup; Brandon Yeo Pei Hui; Nicolas Vidal; Alan R Cookson; Hannah Vallin; Toby Wilkinson; Denise M S Bazzolli; Jennifer Richards; Mandy Wootton; Ralf Mikut; Kai Hilpert; Marc Maresca; Josette Perrier; Matthias Hess; Hilario C Mantovani; Narcis Fernandez-Fuentes; Christopher J Creevey; Sharon A Huws
Journal:  NPJ Biofilms Microbiomes       Date:  2022-07-14       Impact factor: 8.462

4.  Biomechanics and thermodynamics of nanoparticle interactions with plasma and endosomal membrane lipids in cellular uptake and endosomal escape.

Authors:  Chiranjeevi Peetla; Shihua Jin; Jonathan Weimer; Adekunle Elegbede; Vinod Labhasetwar
Journal:  Langmuir       Date:  2014-06-18       Impact factor: 3.882

5.  The rumen microbiome: an underexplored resource for novel antimicrobial discovery.

Authors:  Linda B Oyama; Susan E Girdwood; Alan R Cookson; Narcis Fernandez-Fuentes; Florence Privé; Hannah E Vallin; Toby J Wilkinson; Peter N Golyshin; Olga V Golyshina; Ralf Mikut; Kai Hilpert; Jennifer Richards; Mandy Wootton; Joan E Edwards; Marc Maresca; Josette Perrier; Fionnuala T Lundy; Yu Luo; Mei Zhou; Matthias Hess; Hilario C Mantovani; Christopher J Creevey; Sharon A Huws
Journal:  NPJ Biofilms Microbiomes       Date:  2017-12-01       Impact factor: 7.290

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.